RICHMAP
RICHMAP · Stock · NEW YORK STOCK EXCHANGE, INC. ← Markets

SYK · NEW YORK STOCK EXCHANGE, INC.

Stryker Corp

Health Care
$303.13
▼ 4.86 (1.58%)
Finnhub · 26. 9. 5. 오전 5:00 기준 (실시간~15분 지연)
GLOBAL MARKET WIRE SYK

Stryker Corp를 보는 글로벌 시선

이 종목 직접 발언을 우선한 글로벌 증권사·투자대가의 공개 원문 · RICHMAP 추천 아님

LOAD
CALL TRACKER검증 전체 →
차트 TradingView

재무 요약

Finnhub /stock/metric · 연간 기준 · 캐시 6h
PER (연간)
36.55
EPS (연간)
8.40
매출/주 (연간)
64.98
총이익률 (연간)
64.57%
영업이익률 (연간)
19.36%
순이익률 (연간)
데이터 없음
ROE
14.48%
배당수익률
1.02%
52주 최고
396.86
52주 최저
281
시총 (M)
116,272 USDM
상장 주식수 (M)
383.36

▸ Finnhub /stock/profile2 · 캐시 24h · 모든 수치 API 원값 (RICHMAP 가공·추정 없음)

관련 뉴스

Finnhub /company-news · 최근 14일 · 캐시 30min
Yahoo · 2026. 9. 5.

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Portage, Michigan, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as p…

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 5.

Stryker (SYK) is Buying ZuriMED. Can FiberLocker Strengthen its Shoulder Portfolio?

Stryker Corporation (NYSE:SYK) signed a definitive agreement to acquire privately held ZuriMED, which would add the commercialized FiberLocker System to its shoulder portfolio upon closing. FiberLocke…

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 5.

How Much Upside Can BSX Stock's Growth Deliver?

While two high-profile segments - WATCHMAN and Electrophysiology - have stumbled, the market is overlooking the company's core stability. Business units representing roughly 75% of revenue are perform…

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 4.

Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money

Both Intuitive Surgical and Stryker just posted their fifth straight earnings beat, and Wall Street is cheering for both. But a structural difference buried inside their business models quietly separa…

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 4.

Boston Scientific's ICVT Business Gains Momentum: Can Growth Continue?

BSX's ICVT sales have jumped 15% as coronary therapies gained traction, while new devices and deals could extend its growth momentum.

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 4.

Stryker Launches FDA-Cleared Apple Vision Pro Surgical App

SYK's FDA-cleared SportSuite Vision brings Apple Vision Pro into hip arthroscopy, strengthening its digital surgery push and Sports Medicine portfolio.

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 3.

Medical Devices & Supplies - Diversified Stocks Q2 Teardown: Stryker (NYSE:SYK) Vs The Rest

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Stryker (NYSE:SYK) and the best and worst p…

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 3.

ISRG Stock: The Best House On The Block Costs The Most

In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium.

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 3.

The Wide Divide Priced Into Boston Scientific Stock

The market's valuation reflects a wide breadth of potential outcomes for the company, exposing shareholders to the full magnitude of that underlying risk.

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 2.

Enovis inks eCential takeover to develop surgical ortho robots

The orthopedics specialist aims to launch a knee robot in late 2028, followed by a shoulder robot in 2029.

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 2.

Sector Update: Healthcare Stocks Rise Tuesday Afternoon

Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index adding 0.7% and the

원문 보기 ↗ Yahoo
Yahoo · 2026. 9. 2.

Stryker (SYK) Wins FDA Nod And Completes First Procedure With New Surgery Software

Stryker (NYSE:SYK) received FDA De Novo authorization for its SportSuite Vision software on Apple Vision Pro in a clinical setting. The company reported completion of the first surgical procedure usin…

원문 보기 ↗ Yahoo
⚡ WHAT-IF ARENA · SIMULATION · 가상 · 실제 거래 아님

내 성향 트레이더로 도전

주어는 당신의 성향이지 이 종목이 아닙니다. 6시간부터 1년까지 운용기간을 고르면, AI가 기간에 맞는 주기로 가상 매매합니다. 페이지를 닫아도 서버에서 계속 진행됩니다.

⚠ 정보 제공 목적 · 투자 추천·자문 아님

본 페이지는 정보 제공 목적의 종목 정보 색인이며, 투자 권유·자문·중개가 아닙니다. RICHMAP은 증권사·금융투자업자가 아닙니다. 시세·재무·뉴스는 외부 데이터 소스(Finnhub 등)의 정보로 실시간성·정확성을 보증하지 않습니다. 모든 수치는 API 원값으로 RICHMAP의 가공·추정이 없으며, 조회 실패 시 "데이터 없음"으로 명시됩니다. 투자 판단과 그 결과 책임은 본인에게 있으며, 실제 거래는 정식 인가 증권사를 통해 본인 판단하에 진행하시기 바랍니다.